Page 40 - Ethical Guidelines for Conducting Research Studies Involving Human Subjects
P. 40

      Research  should  be  performed  on  patients  undergoing  the
                                 procedures    for  diagnostic  or  therapeutic  purposes  and  safety
                                 measures should be taken for those as well as for others who may
                                 be exposed to radiation

                                The  protocol  should  make  adequate  requirements  for  detecting
                                 pregnancies to avoid risks of exposure to the embryo.

                                Non-radioactive diagnostic agents are considered as drugs and  the
                                 same guidelines that are used for   drugs  should  be  followed  when
                                 using them.

                          10.5   TRADITIONAL  AYURVEDA,  UNANI  (AU)  REMEDIES  AND
                                 MEDICINAL PLANTS

                          Ethical Issues in Clinical Trials with Herbal Products

                          Herbal  and  other  traditional  pharmacologic  therapies  are  in  widespread
                          use  throughout  the  world.  Such  widespread  use  suggests,  but  does  not
                          assure,  that  traditional  medicines  have  a  favorable  risk-benefit  ratio.
                          Rather,  traditional  medicines  may  be  regarded  as  a  rich  source  of
                          potentially attractive therapies. The actual benefits and risks remain to be
                          evaluated  by  clinical  trials  supported  and  conducted  according  to  the
                          principles of modern clinical science.

                          All  of  the  fundamental  ethical  principles  of  human  participation  in
                          research  apply  equally  to  herbal  remedies  and  research  involving  these
                          compounds. Consent must be obtained, subject selection must be equitable,
                          risks and benefits must be weighed and must be favorable to the potential
                          participant, and experimental design must be sound.

                          Concerns  that  particularly  apply  to  clinical  trials  with  herbal  products
                          include:

                          -      Product adulteration
                          -      Interactions between herbal remedies and other entities
                          -      Reproductive and organ toxicity data
                          -      Prior dose finding

                          The uncertainty in these areas must be clearly disclosed to all concerned,
                          particularly during the informed consent process.

                          In many regions of the world, strong belief that herbal medicines will be
                          beneficial and safe may introduce bias, which can be minimized by careful
                          attention  to  study  design  including  appropriate  control  groups.  Where
                          possible,  the  community  from  whom  the  medicine  originates  should  be
                          consulted during the course of the research, and the results and benefits of
                          the research should be shared with this community.



                   BMRC ETHICAL GUIDELINE ON HUMAN SUBJECTS                                   Page 36
   35   36   37   38   39   40   41   42   43   44   45